Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial.
Markowski MC, Taplin ME, Aggarwal R, Sena LA, Wang H, Qi H, Lalji A, Sinibaldi V, Carducci MA, Paller CJ, Marshall CH, Eisenberger MA, Sanin DE, Yegnasubramanian S, Gomes-Alexandre C, Ozbek B, Jones T, De Marzo AM, Denmeade SR, Antonarakis ES.
Markowski MC, et al. Among authors: taplin me.
Nat Commun. 2024 Jan 2;15(1):14. doi: 10.1038/s41467-023-44514-2.
Nat Commun. 2024.
PMID: 38167882
Free PMC article.
Clinical Trial.